Pill rollout stymied by shortages nationwide
Two new COVID-19 pills from Pfizer and Merck remain in short supply as manufacturing ramps up. Limited initial deliveries and six to eight month production times slow uptake while doctors ration treatments to high risk patients and seek to curb hospital strain amid Omicron.
MENTIONED IN THIS ARTICLE
Washington
U.S
Omicron
Erin McCreary
University of Pittsburgh Medical Center
University of North Carolina
Myron Cohen
Food and Drug Administration
Pfizer
Merck
White House
Jeff Zients
Includ
New York
Mary Bassett
Michigan
Pennsylvania
Maryland
Texas
Craige Campbell
Desert Hot Springs
California
Campbell
UPMC
University of Maryland Medical Center
Greg Schrank
Schrank
The
Coinfection of Flu and Corona Not a New Virus Thing
Coinfection with influenza and the coronavirus is real but not a new or hybrid virus. Experts say the two viruses can infect a person at the same time, with outcomes influenced by timing, immune response, and prior vaccination. Prevention includes masks, ventilation, vaccines, and staying home when sick.
MENTIONED IN THIS ARTICLE
Isabella Cattadori
Pennsylvania State University
Thomas Fekete
Temple University
Katz School of Medicine
Sara Cherry
University of Pennsylvania Perelman School of Medicine
A.J. Te Velthuis
Princeton University
Saad Omer
Yale Institute of Global Health
New York Times
Cherry
COVID
Velthuis
Princeton
Penn State
Cattadori
Temple
Also Mentioned on This Page
Merck & CO
AP Merck
Fekete
Jerusalem Post
Israel
al Yankovic
Conan O’brien
Flaron
Tribune News Service
Ohio National Guard
Akron